Hajime Ueda - Nomura Research Director
| NRILY Stock | USD 30.40 0.48 1.55% |
Director
Hajime Ueda is Executive Officer, Deputy Chief Director of China & Asia System Business, Manager of General Planning Center of Nomura Research Institute since 2019.
| Tenure | 5 years |
| Phone | 81 3 5533 2111 |
| Web | https://www.nri.com |
Nomura Research Management Efficiency
The company has return on total asset (ROA) of 0.083 % which means that it generated a profit of $0.083 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2041 %, meaning that it generated $0.2041 on every $100 dollars invested by stockholders. Nomura Research's management efficiency ratios could be used to measure how well Nomura Research manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| CeCelia Morken | Genpact Limited | 63 | |
| Laura Conigliaro | Genpact Limited | 75 | |
| Charles Revoile | CACI International | 85 | |
| Ajay Agrawal | Genpact Limited | 51 | |
| Jonathan Holman | ASGN Inc | 74 | |
| James Pavitt | CACI International | 74 | |
| Brett Keller | Broadridge Financial Solutions | 51 | |
| Alan Weber | Broadridge Financial Solutions | 71 | |
| Brian Callaghan | ASGN Inc | 49 | |
| William Jews | CACI International | 68 | |
| Mark Nunnelly | Genpact Limited | 61 | |
| Debora Plunkett | CACI International | 60 | |
| Thomas Perna | Broadridge Financial Solutions | 68 | |
| Carol Lindstrom | Genpact Limited | 67 | |
| Maura Markus | Broadridge Financial Solutions | 63 | |
| Mariel Joliet | ASGN Inc | 54 | |
| Mark Verdi | Genpact Limited | 54 | |
| Robert Duelks | Broadridge Financial Solutions | 65 | |
| Pamela Carter | Broadridge Financial Solutions | 71 | |
| Edwin Sheridan | ASGN Inc | 50 | |
| Amit Zavery | Broadridge Financial Solutions | 49 | |
Management Performance
| Return On Equity | 0.2 | |||
| Return On Asset | 0.083 |
Nomura Research Institute Leadership Team
Elected by the shareholders, the Nomura Research's board of directors comprises two types of representatives: Nomura Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nomura. The board's role is to monitor Nomura Research's management team and ensure that shareholders' interests are well served. Nomura Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nomura Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fumihiko Sagano, Executive Officer, Chief Director of Basic Service Business | ||
| Tomoshiro Takemoto, Executive Officer, Chief Director of Cloud Service Business | ||
| Kuniaki Fujioka, Investor Exec | ||
| Yoichi Inada, Executive Officer, Manager of Human Resources Development Center | ||
| Takuhito Sakata, Executive Officer, Chief Director of Data Center Management | ||
| Shigeki Hayashi, Executive Officer, Chief Director of Insurance Solution Business | ||
| Yoshihiko Sunaga, Sr Fin | ||
| Shingo Konomoto, Managing Executive Officer, Chief Director of Consulting Business | ||
| Hiroshi Masutani, Executive Officer, Deputy Chief Director of IT Basic Innovation Business, Director of DI Solution Business, Director of Product Development and Presidentident of Subsidiary | ||
| Hajime Ueda, Executive Officer, Deputy Chief Director of China & Asia System Business, Manager of General Planning Center |
Nomura Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nomura Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.083 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 14.79 B | |||
| Shares Outstanding | 590.09 M | |||
| Price To Earning | 21.15 X | |||
| Price To Book | 5.14 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 611.63 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nomura Pink Sheet Analysis
When running Nomura Research's price analysis, check to measure Nomura Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nomura Research is operating at the current time. Most of Nomura Research's value examination focuses on studying past and present price action to predict the probability of Nomura Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nomura Research's price. Additionally, you may evaluate how the addition of Nomura Research to your portfolios can decrease your overall portfolio volatility.